TeleVox vs. Seegnal

For over thirty years, TeleVox has been a catalyst for enhancing communication between healthcare providers, pharmaceutical companies, and life sciences organizations, which in turn fosters trust, ensures continuity of care, and enriches the overall patient experience. Our cutting-edge digital engagement solutions serve a network of over 10,000 healthcare providers, facilitating smooth communication with patients at every stage of their healthcare journey—before, during, after, and in-between their appointments. Furthermore, our customized services for the pharmaceutical and life sciences sectors help in reaching a wider patient audience through targeted initiatives that emphasize disease awareness, educational materials, and reminders for vaccinations. We enable our clients to connect with patients at the ideal moments through a variety of effective communication methods, including SMS text, phone calls, live chat virtual assistants, emails, and postcards. This strategy not only delivers personalized and adaptable messages that enhance patient satisfaction and fill gaps in care but also increases revenue while reducing the strain on healthcare personnel. By nurturing these vital connections, we play a key role in creating a more efficient and responsive healthcare ecosystem, ultimately contributing to better health outcomes for the communities we serve. Additionally, our commitment to innovation ensures that we are continually evolving to meet the changing needs of both healthcare providers and patients alike.

An intuitive real-time user interface created for use at the point of care significantly improves the prevention of Drug-Related Problems (DRPs) tailored to individual patients. DRPs rank as the fourth leading cause of mortality in the United States, resulting in around 150,000 deaths annually and comprising 6-10% of all hospital admissions. Moreover, patients who are prescribed five or more medications face over a 20% likelihood of experiencing serious DRPs, which in turn contribute to billions of dollars in avoidable healthcare expenses. Each month, nearly 4.5 million individuals in the U.S. visit emergency rooms due to complications arising from DRPs. The platform features the most extensive data integration available, offering 50% more unique information and the ability to synchronize data from multiple sources. By leveraging AI and machine learning, it delivers real-time insights customized to each patient, incorporating factors such as lab results, estimated glomerular filtration rate (eGFR), genetic profiles, dietary habits, and usage of over-the-counter drugs. With a remarkable accuracy rate of 98% for both specificity and sensitivity, it significantly reduces alert fatigue by generating only 6% of the alerts typically issued by conventional systems. Additionally, the patented visualization technology employed at the point of care facilitates the swift detection, prioritization, and resolution of issues within a rapid timeframe of just 5 to 10 seconds, ensuring that patient care is both timely and effective. This cutting-edge methodology not only reduces the risks linked to DRPs but also promotes overall healthcare efficiency, ultimately leading to improved patient outcomes and satisfaction.